Doricum eye drops

Doricum is a pharmaceutical product developed by Laboratoires Théa, a French company specializing in ophthalmology. The product is manufactured in various countries, including France, Italy, and Austria, to meet the global demand for eye care solutions. Laboratoires Théa is an independent, family-owned company founded in 1870, with its headquarters in Clermont-Ferrand, France. The company has expanded its presence internationally, including subsidiaries in the United States, such as Thea Pharma Inc. in Waltham, Massachusetts. In 2022, Théa completed the acquisition of Akorn's branded ophthalmic products, further strengthening its position in the U.S. eye care market. Thea Pharma Inc. operates as a subsidiary of Laboratoires Théa, focusing on the distribution and promotion of Théa's ophthalmic products in the United States.